Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Patient Data In Drug Reviews Would Be Encouraged In Proposed Amendment To User Fee Bill
May 12 2022
•
By
Brenda Sandburg
FDA may have to disclose how it uses patient experience data in drug reviews • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA
More from Agency Leadership